Journal of Hematology Oncology Pharmacy

Featured Articles

Dosing Chemotherapy in Obese Patients, Still Not Answered

Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant

Evaluating Antibiotic Use and Opportunities for Intervention in Patients with Cancer

Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer

CAR T-Cell Therapy: Review of the Newest Weapon in the Battle Against Hematologic Malignancies

Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient

From the Literature

Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70

Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer

New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America

Low-Dose Capecitabine Maintenance Therapy Improves Survival in Patients with Triple-Negative Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Enfortumab Vedotin Superior to Chemotherapy in Urothelial Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Oral Azacitidine Prolongs Survival in Patients with Acute Myeloid Leukemia

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

FDA Oncology Update

Cytalux, a Novel Imaging Agent, FDA Approved for Diagnosing Inoperable Ovarian Cancer Lesions

FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor

Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia

Darzalex Faspro, Kyprolis, and Dexamethasone a New Combination FDA Approved for Multiple Myeloma

Keytruda Now FDA Approved for Adjuvant Treatment of Renal-Cell Carcinoma

Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer

Meeting Highlights

Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient

The Impact of Telehealth on Cancer Care

The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs

Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care

Drug Price Reform with Value in Mind: Can It Happen?

Study Shows mRNA COVID-19 Vaccine Effective and Safe in Patients with Cancer Undergoing Treatment

Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.